Development
Gilead Sciences, Inc.
GILD
$112.46
-$2.05-1.79%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -12.87% | 21.91% | -8.65% | 5,215.79% | 329.32% |
| Total Depreciation and Amortization | 30.30% | 30.29% | 29.71% | 21.90% | -1.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.99% | -34.08% | -61.72% | -74.13% | -40.51% |
| Change in Net Operating Assets | -564.10% | -1,223.93% | 155.07% | 53.36% | -93.55% |
| Cash from Operations | -15.50% | -38.70% | 29.74% | -5.22% | -19.91% |
| Capital Expenditure | -18.78% | 22.29% | 2.80% | 55.87% | -16.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -27.98% | 82.37% | 25.00% | 31.72% | -395.45% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,070.83% | 74.07% | -163.52% | -937.50% | 130.77% |
| Cash from Investing | -93.87% | 67.88% | -56.82% | 22.80% | -34.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -125.00% | -- | -- | 100.00% |
| Issuance of Common Stock | -85.23% | 130.56% | 766.67% | 3.19% | 1,366.67% |
| Repurchase of Common Stock | 81.06% | -66.67% | -108.33% | -13.64% | -1,516.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.06% | -2.58% | -2.61% | -2.54% | -2.35% |
| Other Financing Activities | -43.48% | -73.33% | -135.71% | -47.25% | -109.09% |
| Cash from Financing | 29.28% | 28.28% | -9.77% | 21.63% | 19.98% |
| Foreign Exchange rate Adjustments | -50.67% | 91.67% | 127.08% | 172.22% | 933.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.70% | 102.50% | 73.36% | 54.32% | -26.95% |